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Background: Primigravidity is one of the main risk factors for both malaria and anaemia. Since the implementation
of intermittent preventive treatment (IPTp) in sub-Saharan Africa, the relationship between anaemia and gravidity
and its evolution during pregnancy has been little explored. This study aimed to evaluate the impact of gravidity
on the variation of haemoglobin during pregnancy according to the timing of gestation.
Methods: Data from three studies carried out in nearby areas in south Benin (Ouidah, Comé, Allada) between
2005 and 2012 were analysed. At inclusion (first antenatal visit, ANV1) women’s age, area of residence, schooling,
gravidity, gestational age, weight and height were recorded. Thick blood smears were performed on ANV1,
second visit (ANV2) and at delivery. In Allada, women’s serum ferritin and CRP concentrations were also assessed.
The impact of gravidity on maternal haemoglobin (Hb) was analysed using a logistic or linear regression
depending on the outcome. The statistical significance was set to P < 0.05.
Results: In total, data from 3,591 pregnant women were analysed. Both univariate and multivariate analyses
showed a constant association between Hb concentrations and gravidity in the three periods of Hb assessment
(ANV1, ANV2 and delivery). Mean Hb concentration was significantly lower in primigravidae than in multigravidae
at ANV1 (mean difference = -2.4 g/L, CI 95%: [-3.4, -1.4], P < 0.001). Afterwards, there was a significant increase in
primigravidae only, with a tendency to reversal between primigravidae and multigravidae, which was confirmed
at delivery (mean difference = 2.8 g/L, CI 95%: [1.3, 4.2], P < 0.001). The prevalence of malaria infection was halved
between ANV1 and delivery in primigravidae while it decreased by only 38% among multigravidae, who were
less prone to malaria infection (prevalence at ANV1, 20% and 10% respectively). Iron deficiency was more common
in multigravidae, and it decreased slightly in this group between ANV1 and delivery.
Conclusion: In a context of IPTp, Hb levels improved progressively throughout pregnancy in primigravidae, likely as
a result of reduction in malaria infection. In multigravidae, the improvement was less perceptible and anaemia was
mainly due to iron deficiency.
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As part of the prospective cohort study (Anaemia in
Pregnancy: Etiologies and Consequences “APEC”) car-
ried out in Benin between 2010 and 2012, primigravidae
and multigravidae were followed from the first antenatal
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distribution, and reproduction in any mediumanalyses showed that the administration of anti-parasitic
treatments (IPTp with SP or mefloquine and albenda-
zole) at ANV1 significantly decreased the prevalence of
malaria infection and helminths. Furthermore, these
analyses showed that malaria and helminth infestations
were no longer associated with anaemia at the second
antenatal visit (ANV2). At ANV2, the effect of primigra-
vidity on anaemia, particularly marked at enrolment,
also disappeared, suggesting this group could be particu-
larly sensitive to preventive measures.
First pregnancy is recognized as one of the main
risk factors for both malaria and anaemia [2-4]. Thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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nancy have seldom been investigated, although an early
study in Papua New Guinea, where pregnant women
received neither malaria prophylaxis nor haematinics,
reported that the differences in Hb levels between
malaria-positive at booking and malaria-negative at deliv-
ery were higher in primigravidae than in multigravidae [5].
However, since the implementation of IPTp in sub-
Saharan Africa, no clinical trial has studied the effect of
malaria-focused preventive measures on anaemia in rela-
tion to gravidity. To evaluate the impact of gravidity on
the variation of Hb during pregnancy according to the
timing of gestation, data from APEC were analysed and
further pooled with two earlier studies, which had fol-




The three studies were approved by the Ethics Commit-
tees of the Research Institute for Development in France,
and of the Faculty of Medicine of Cotonou in Benin.
Before each inclusion, written informed consent was
obtained from all participants.
Study sites and population
The study sites and populations have been described
elsewhere [6-8]. Briefly, the three studies were con-
ducted in three rural or semi-rural areas located within
a 50 km radius in south Benin (Ouidah, Come, Allada).
In the whole area, malaria is perennial and Plasmodium
falciparum is the commonest species. There are two
high transmission peaks from April to July and October
to November. The study population was composed of
HIV-negative pregnant women who attended one of the
nine study maternity clinics (three in each site) during
the period of the studies.
Ouidah study
This study is a randomized controlled clinical trial,
which took place from 2005 to 2008 in Ouidah, a 35,000-
inhabitant semi-rural area located 40 km west of Cotonou,
in three maternity clinics (Kindji, Kpassé, Hopital
de Zone). It compared the efficacy of sulphadoxine-
pyrimethamine SP (1,500/75 mg per dose) vs mefloquine
(15 mg/kg per dose) given for IPTp on birth weight.
The first IPTp dose was administered between 16 and
28 weeks, and the second dose after 30 weeks of gestation,
with at least one month from the first dose intake [6].
STOPPAM study (strategy to prevent pregnancy-
associated malaria)
STOPPAM is a cohort study of pregnant women, set up
in three maternity clinics (Comé central, Ouedeme-Pedah, Akodeha) in the district of Comé, with a popula-
tion of 58,396 inhabitants. The district of Comé is a
rural area located 70 km west of Cotonou. STOPPAM
aimed to investigate the development of immune
response to malaria in pregnancy. This study was carried
out between 2008 and 2010. Two doses of SP-IPTp
were administered according to the national guidelines,
the first dose of IPTp being administered between 16
and 24 weeks of gestation. Women were followed up
monthly from inclusion to delivery [7].
APEC study (anaemia in pregnancy: etiology and
consequences)
APEC is an observational cohort study nested in MiPPAD
(Malaria in Pregnancy Preventive Alternative Drugs), a
randomized trial comparing the efficacy of IPTp with SP
(1,500/75 mg per dose) and mefloquine (15 mg/kg per
dose). APEC took place in three maternity clinics in
the district of Allada (Allada, Attogon, Sékou), between
2010 and 2012. The district of Allada is a semi-rural area
of 91,778 inhabitants located 50 km north of Cotonou.
As in the Ouidah study, the first dose of IPTp was admi-
nistered between 16 and 28 weeks of gestation [8].
In the three studies, women were encouraged to con-
sult in case of symptoms any time between scheduled
ANVs. Women were systematically given supplements
of oral ferrous sulfate (200 mg per day) and folic acid
(5 mg per day) for home treatment, according to the
guidelines of the Beninese Ministry of Health (MoH) in
APEC and STOPPAM studies. In the Ouidah study, the
daily dose of ferrous sulphate was 400 mg and folic acid
was unchanged (5 mg per day). In the three studies, iron
and folic acid prescription was renewed if necessary.
Theoretically, women were supposed to continue the
supplementation until three months after delivery. In
cases of Hb concentration below 110 g/L, women were
treated according to the severity of anaemia, i e, 200 mg
of oral ferrous sulphate and 5 mg of oral folic acid twice
a day for mild and mode anaemia, and referred to the
tertiary hospital of the district in case of severe anaemia
(Hb <70 g/L). In the latter case, 500 ml of whole blood
were transfused. The total amount of blood transfusion
was raised to 1,500 ml if necessary, according to the
guidelines of the Beninese MoH.
Socio-demographic and clinical data collection
At inclusion (ANV1), socio-demographic data such as
age, area of residence, level of education were recorded.
Women were clinically examined and parity, gestational
age, weight and height were recorded. Weights were
measured to the nearest 0.1 kg by using an electronic
scale (Seca Corp., Hanover, MD) and heights to the
nearest 0.1 cm by using a bodymeter device (SecaW206
Bodymeter; Seca Corp.). Weights and heights were
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surements was calculated for all participants. Body mass
index (BMI) was defined as the women’s weight at enrol-
ment (kg)/height squared (m2). Medical history, includ-
ing the history of previous pregnancies, notation of any
chronic disease (as high blood pressure, diabetes, or
asthma) was also recorded.
At the time of the second antenatal visit (ANV2), at
delivery and during the unscheduled visits, gestational
age, weight and height were measured. Gestational age
was estimated using the date of the last menstrual period
and/or by measuring the fundal height.
Blood sample collection
At ANV1, ANV2 and at delivery, venous blood was col-
lected from each participant to determine Hb concentra-
tions and to perform thick blood smears in search of
peripheral malaria. At delivery, a placental blood smear
was also performed to look for placental malaria. In the
APEC study, blood was collected into dry tubes to deter-
mine women’s serum ferritin and CRP concentrations.
Serum ferritin and C-reactive protein (CRP) concentra-
tions were used to evaluate women’s iron stores. Iron
deficiency was defined as serum ferritin < 12 μg / L or
as serum ferritin between 12 and 70 μg/L in the context
of inflammation defined as a positive CRP, i.e., CRP con-
centration > 5 mg/mL.
Laboratory tests
The laboratory methods have been described else-
where [6-8]. Haemoglobin concentration was measured
with either with a haematology analyser (Erma Labo-
ratory, Japan) or Hemo_ControlW (EKF Diagnostics,
Germany) device.
In the Ouidah randomized trial and STOPPAM, blood
smears were performed using the standard method.
Thick blood smears were stained with Giemsa and read
at x100 oil immersion. Smears were considered negative
if no asexual stage of malaria parasite was detected after
counting 500 leucocytes. Malaria parasites were counted
against 200 leucocytes [9].
In APEC, the Lambaréné technique was used. It con-
sists of spreading 10 μL of blood on a slide’s rectangular
area of 1.8 cm2 (1.8 cm x 1 cm). The slide is then stained
with Giemsa and read at x100 oil immersion. A multipli-
cation factor is applied to the average parasitaemia/field
to get a number of parasites/μL. The Lambaréné method
detection threshold has been estimated to five parasites/
μL [10]. Serum ferritin was measured by using an
AxSym Immuno-Assay Analyzer (Abbott Laboratories,
Abbott Park, IL) with 500 mL of serum. The concentra-
tions of serum CRP were determined by using a rapid
slide test (CRP Latex; Cypress Diagnostics Inc., Camp-
bellville, Ontario, Canada).Statistical analysis
Data were analysed with Stata version 11 for Windows
(Stata Corp, College Station, TX, USA).
Definition of outcome variables
Maternal Hb status was considered first as a continuous
variable, and then as a categorical variable. Anaemia
was defined as Hb below 110 g/L. Severe, mode and
mild anaemia were defined as Hb concentrations less
than 70 g/L, between 70 and 99 g/L and between 100 g/L
and 109 g/L, respectively [11].
Comparison of the three studies
Baseline characteristics of the women and the outcomes
(maternal Hb concentrations and maternal anaemia at
each blood assessment) were compared between the
three studies. Other anaemia risk factors such as mal-
aria, placental malaria and the timing of IPTp intakes
were also compared. Proportions and means were com-
pared using Chi2 test and Student’s test.
Effects of gravidity on maternal haemoglobin
concentrations and maternal anaemia
To determine the impact of gravidity on maternal Hb sta-
tus, analyses were first separately performed on the data
from each study. Afterwards, the data from the three
studies were pooled to perform a logistic or linear regres-
sion depending on the outcome (binary or continuous).
To account for the timing of anti-malarial interven-
tions, two variables measuring the intervals between
IPTp1 and IPTp2, and IPTp2 and the end of the preg-
nancy were created. All variables with a P value less than
0.2 were considered as covariates for the multivariate
linear or logistic regressions. The statistical significance
of final models was set to P <0.05.
Results
Comparison of women’s general characteristics between
the three studies
Three thousand, five hundred and ninety one (3,591)
women were included in this analysis. One thousand, six
hundred and one (1601) women were from the Ouidah
trial, 985 women from STOPPAM and 1,005 women
from APEC. Haemoglobin concentrations were assessed
in 98% (72/3591) of the women at ANV1 and 89.4%
(335/3164) at delivery.
The general characteristics of women and the out-
comes of the three studies are presented in Table 1.
The proportion of women who received education
was higher in Ouidah than in STOPPAM and APEC
(P <0.001). The proportions of women less than 21 years
old (median age) did not differ between the three studies
(P = 0.22), but there were more primigravidae in Ouidah
than in STOPPAM and APEC (P <0.001). The overall
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mass index (BMI) on inclusion did not differ signifi-
cantly between the three studies (P = 0.07), but there
was a tendency for a lower BMI in Ouidah. Placental
malaria was more common in STOPPAM and APEC
than in Ouidah (11.2%, 9.2% and 3.0% respectively).
On average, women were given first and second doses
of IPTp earlier in STOPPAM and APEC than in Ouidah
(P = 0.001), but there was no significant difference
between gestational ages at delivery (P = 0.15). The time
intervals between IPTp intake was highest in Ouidah
whereas the interval between IPTp2 and delivery was
less in Ouidah than in STOPPAM and APEC. Mean Hb
was higher at each blood assessment in Ouidah than in
STOPPAM and APEC, and in the three studies thereTable 1 Comparison of women’s general characteristics betw
Factors Ouidah study
Area Semi-ru









BMI at inclusion (kg /m2) ( % )
<20 81.0
≥20 19.0
Interval between ANV1 and ANV2 (weeks) mean (SD) 8.6 (3.
Interval between ANV2 and delivery (weeks) mean (SD) 8.6 (3.
Gestational age at ANV1 (weeks) mean (SD) 24.2 (2.




Severe anaemia at ANV1 (%)
Yes 1.4
No 98.6
Severe anaemia at delivery (%)
Yes 1.0
No 99.0
Haemoglobin at ANV1 (g / L) mean (SD) 104.1 (14
Haemoglobin at ANV2 (g / L) mean (SD) 105.2 (13
Haemoglobin at delivery (g / L) mean (SD) 113.7 (16
Number of antenatal visits mean (SD) 3.1 (0.
SD: Standard deviation; BMI: Body Mass Index; ANV: Antenatal visit.was a marked tendency to an increase in Hb concentra-
tions from ANV1 to ANV2 and delivery, as described
previously for APEC and the Ouidah trial [1,12]. For
these reasons, we decided to include the factor “study”
as an adjustment covariate in the multivariate analyses.
Twenty point five percent (20.5%) of the women had
inflammation (CRP > 5 ml / ml) at ANV1 and 34.3%
at delivery. The geometric means of malaria parasite
density were 601.8 (CI95%: [544.6-735.1]) at ANV1 and
3294.5 (CI95%: [2208.3-4447.1]) at delivery.
Relationship between maternal haemoglobin status
and gravidity throughout pregnancy
When considering studies separately, there was an over-
all suppress differences between primigravidae andeen the three studies
n = 1601 STOPPAM n = 985 APEC n = 1005 P value
ral Rural Semi-rural








2) 5.1 (1.5) 6.4 (1.8) 0.0001
3) 13.9 (3.9) 12.2 (5.4) 0.0001
8) 20.6 (3.1) 22.1 (4.1) 0.0001
9) 39.4 (2.7) 39.3 (3.2) 0.15






.0) 102.0 (11.5) 103.2 (12.37) 0.0004
.4) 102.1 (10.5) 105.1(10.8) 0.0001
.3) 110.0 (14.0) 111.5 (14.4) 0.0001
7) 3.7 (1.3) 3.5 (1.0) 0.0001
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cance. After pooling data from the three studies, both
univariate and multivariate analyses showed a constant
association between Hb concentrations and gravidity in
the three periods of Hb assessment (Table 2). Mean Hb
concentration was significantly lower in primigravidae
than in multigravidae at ANV1 (p < 0.001). Afterwards,
it increased significantly in primigravidae only, with a
tendency to reversal of the difference between primi-
gravidae and multigravidae, which was confirmed at de-
livery (p < 0.001), and an overall increase in all women.
The following covariates were associated to lower
Hb levels at ANV1: gestational age more than or equal
to 16 weeks (P < 0.001), malaria (P < 0.001), low BMI
(P = 0.001), study (STOPPAM and APEC studies vs
Ouidah study, P < 0.001). At ANV2, malaria (P < 0.001),
low BMI (P < 0.001), study (STOPPAM and APEC stud-
ies vs Ouidah study, P < 0.001) were associated to lower
Hb levels. At delivery, gestational age higher than or
equal to 37 weeks (P = 0.005) and more than four ANVs
during the follow-up (P = 0.003) were associated with a
higher Hb concentration, whereas malaria (P < 0.001)
and low BMI (P = 0.012) were related to lower Hb levels.
When maternal Hb was considered as a categorical
variable (anaemia or no anaemia), primigravidity
remained associated with a better Hb status at delivery
(aOR = 0.7, P = 0.003) (Table 3). The following cov-
ariates were related to an increased risk of maternal
anaemia on ANV1: gestational age more than 16 weeks
(P = 0.004), age below 21 years (P = 0.002), study
(STOPPAM and APEC vs Ouidah study, P < 0.001),
malaria (P < 0.001) and low BMI (P < 0.001). On ANV2,
only STOPPAM study (P < 0.001), malaria (P = 0.001)
and low BMI (P = 0.01) were still associated with a
higher risk for maternal anaemia. At delivery, a high
number of ANVs (more than four) (P = 0.001) was asso-
ciated with a decreased risk for maternal anaemia,Table 2 Relationship between mean haemoglobin (Hb) and g
Gravidity Hb (g / L) Crude differe
Mean CI95%
ANV1
Primigravidae (n = 786) 100.9 −3.1 [-4.1, -2
Multigravidae (n = 2733) 104.0
ANV2
Primigravidae (n = 721) 105.0 0.8 [-0.1, 1
Multigravidae (n = 2520) 104.2
Delivery
Primigravidae (n =588) 113.8 2.1 [0.7, 3
Multigravidae (n =2241) 111.7
*Reference class is multigravidae.
§Adjusted for malaria on the visit, BMI, number of ANVs, intervals between ANV1 anwhereas malaria (P < 0.001) was related to a higher risk
of maternal anaemia.
Relationship between gravidity, malaria infection and iron
deficiency throughout pregnancy
The relationships between the two main aetiologies of
anaemia, malaria and iron deficiency, and gravidity are
presented in Table 4. On ANV1 and delivery, malaria
was more frequent in primigravidae, but the overall
decrease of malaria between ANV1 and delivery was
more important in primigravidae compared with multi-
gravidae (more than 50% of reduction in primigravidae
vs less than 38% in multigravidae). Iron deficiency was
assessed only in the APEC study. At ANV1, ANV2 and
delivery, iron deficiency was more common in multi-
gravidae, but the difference was only significant at
ANV1 and ANV2.
Discussion
This study showed that if primigravidae were the most
vulnerable group to anaemia at the beginning of preg-
nancy, they rapidly increased their Hb to reach higher
levels than multigravidae at delivery. Protective interven-
tions against malaria (i e, IPTp) appeared to play a major
role in this process, which was demonstrated in three
studies conducted in different areas at different times in
southern Benin.
Although the women come from three different stud-
ies, they nevertheless share common factors. They all
originated from the same region of Benin, with the same
climatic pattern, and potentially similar malaria trans-
mission in all sites [13]. They were all included before
28 weeks of gestation and they had the same average
gestational age at delivery. Moreover, the women did not
differ in the distribution of baseline characteristics such
as age, body mass index at inclusion, which are prone
to influence Hb concentrations [8]. However, althoughravidity throughout pregnancy in south Benin
nce* (g / L) Adjusted difference*§ (g / L)
P value Mean CI95% P value
.0] < 0.0001 −2.4 [-3.4, -1.4] < 0.001
.9] 0.09 1.0 [0.004, 2.0] 0.049
.4] 0.004 2.8 [1.3, 4.2] < 0.001
d ANV2 and between ANV2 and delivery, schooling, study and gestational age.
Table 3 Relationship between risk for maternal anaemia (Hb < 110 g/L) and gravidity throughout pregnancy in south
Benin
Gravidity % of anaemia Crude Odds ratio* Adjusted Odds ratio*§
OR CI95% P value OR CI95% P value
ANV1
Primigravidae (n = 786) 73.9 1.4 [1.1, 1.6] 0.001 1.1 [0.9, 1.4] 0.28
Multigravidae (n = 2733) 68.0
ANV2
Primigravidae (n = 721) 66.0 0.9 [0.8, 1.1] 0.44
Multigravidae (n = 2520) 67.5
Delivery
Primigravidae (n = 588) 36.9 0.8 [0.7, 0.9] 0.02 0.7 [0.6, 0.9] 0.003
Multigravidae (n = 2241) 42.4
*Reference class is multigravidae.
§Adjusted for malaria on the visit, BMI, number of ANVs, intervals between ANV1 and ANV2 and between ANV2 and delivery, schooling, study and gestational age.
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one-month interval between intakes, the study designs
were different: STOPPAM being an observational study
and Ouidah and APEC controlled randomized trials.
The timing of IPTp also differed between the three stud-
ies, the last intake being on average one month closer to
delivery in Ouidah compared with the two other studies
and probably related to a lower prevalence of placental
infection, as stressed by Huynh et al [14]. STOPPAM
study and APEC trial were located in more rural settings
than Ouidah. Finally, investigations were held at differ-
ent times and one can assume that, in particular, resist-
ance of malaria parasites to SP may have progressed
from 2005 until now.
The analyses of data from each of the three studies
separately showed that primigravidae who were initially
at higher risk of anaemia at inclusion (ANV1), increased
progressively Hb concentration and became, although
not significantly, at lower risk of anaemia at deliveryTable 4 Relationship between gravidity, malaria
infections and iron deficiency throughout pregnancy in
south Benin, univariate analyses
Gravidity Malaria infections* Iron deficiency§
n % P value n % P value
ANV1
Primigravidae 791 20.2 < 0.001 190 23.7 0.002
Multigravidae 2751 9.6 815 35.6
ANV2
Primigravidae 727 3.8 0.44 180 26.7 0.003
Multigravidae 2547 3.3 765 38.4
Delivery
Primigravidae 617 9.1 0.005 155 27.7 0.4
Multigravidae 2328 6.0 701 31.2
*Data from the three studies.
§Data from APEC only (Iron status was only assessed in APEC study).compared with multigravidae. Pooling all data from the
three studies increased the sample size and thus the
power of the analysis, demonstrating the importance of
gravidity as a determinant of maternal anaemia, even
after adjusting on the characteristics of each population.
In addition, taking into account gestational age in the
multivariate analyses minimized the effect of potential
confounders such as the gestational plasma volume
changes that might as well have played a role in the
parity-related difference.
Primigravidae had a lower mean Hb and an increased
risk for anaemia in early pregnancy compared to multi-
gravidae, prior to the administration of IPTp. Further-
more, an overall decrease in the proportion of malaria
infections after women were given IPTp has been shown
[1,15-17]. In the study, more than 20% of primigravidae
were infected by malarial parasites at inclusion, whereas
only less than 10% of them were malaria positive at
delivery. At the same time, the proportion of malaria-
infected multigravidae decreased from 10% to 6%. The
decline in the proportion of malaria infections in primi-
gravidae also coincides with the increase of Hb concen-
trations on ANV2 and delivery. Such an increase of Hb
concentrations in primigravidae may then be explained
by the reduction of the proportion of malaria-related
anaemia by IPTp in this group. These results are
in agreement with a large meta-analysis of Hb parity
differences comparing malarious and non malarious
areas [18]. In addition, the demonstration of a better
efficacy of anti-malarial drugs in primigravidae for the
prevention of anaemia had been made in the 1990s,
when chloroquine chemoprophylaxis was still used
[19]. Since the implementation of IPTp with SP, two
observational studies led to conflicting results [20,21].
Rogerson et al showed in Malawian women a decrease
of maternal anaemia only in primigravidae [20], whereas
Hommerich et al showed a decrease of anaemia in only
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of the effects of drugs to prevent malaria-related
illnesses in pregnant women concluded that IPTp was
effective to reduce the risk for peripheral and placental
malaria and maternal anaemia, especially in primi and
secundigravidae [22].
In spite of IPTp and iron supplementation, multigrav-
idae increased Hb levels, but not in the same proportion
as primigravidae, and consequently were at higher risk
of anaemia at delivery. Indeed, in the APEC study, the
proportion of women presenting with iron deficiency
was higher in multigravidae than in primigravidae at
each blood assessment. As previously described [1],
there is a great demand for iron during pregnancy, as
shown by the drop in Hb levels in the second trimester
of gestation. Consequently, the effect of iron supplemen-
tation may be masked and even be insufficient to cover
the needs of the mother and the foetus. In agreement
with this hypothesis, Hernandez-Martinez et al showed
in Spanish, well-nourished, pregnant women (including
primi and multigravidae) who received an iron supple-
mentation (40-60 mg/day) that iron deficiency increased
importantly as pregnancy progressed (from 8% at inclu-
sion to 68% at delivery) [23]. A similar trend was not
observed in APEC. On the contrary, iron deficiency
seemed to decrease in multigravidae (from 35% at
ANV1 to 31% at delivery), suggesting that the effect of
iron supplementation might be better than expected.
In this study, the difference between primigravidae and
multigravidae may be a consequence of an increase in
the prevalence of iron deficiency, due to cumulative iron
requirements of successive pregnancies. Additionally,
closely spaced pregnancies that are frequently observed
in sub-Saharan Africa may exacerbate this phenomenon,
as birth intervals have been found to affect women’s Hb
concentrations, with short intervals being a risk factor
for anaemia [24].
The lack of longitudinal data for pregnant women
with the same definition of iron deficiency makes
comparisons of prevalence of iron deficiency difficult
among studies from sub-Saharan Africa. Nevertheless,
in Kenyan pregnant women of less than 24 weeks’ gesta-
tional age, results close to the findings of this study were
found by Alusala et al [25]. The authors showed that
more than 40% of multigravidae were iron deficient,
defined as serum ferritin concentrations below 12 μg/L
vs less than 19% of primigravidae. This is in agreement
with the results of APEC (36% and 24% in the two
groups).
Conclusion
In the context of IPTp, primigravidae were shown to
have a progressive increase in Hb concentration
throughout pregnancy. The effect of IPTp on anaemia inmultigravidae women was less marked, as they are less
susceptible to malaria and nutritional deficiencies seem
to be the main causes of anaemia in this group. There is
a need to reinforce malaria prevention strategies in both
groups, and to undertake additional measures focusing
on the reduction of micronutrient deficiencies in multi-
gravidae. For instance, women should be encouraged to
take iron supplements from the first pregnancy until
menopause, even at lower doses during the interval
between pregnancies, to reduce iron side effects and
increase compliance. This strategy is relatively easy to
implement as the target population may be identified at
the first pregnancy.
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